by Fish skin disease refers to various pathological conditions that affect the skin of fish. Some common fish skin diseases include ichthyophthirius multifiliis or “white spot disease,” columnaris disease, saprolegnia disease and winter ulcer disease. Fish skin disease can occur during fish farming and aquaculture activities due to various stress factors like poor water quality, injuries, low levels of oxygen in water and infection by parasites. Treatment of fish skin diseases involves administration of antiparasitic drugs, antibacterial and antifungal drugs.
The global fish skin disease market comprises various parasiticides, antibiotics and fungicides used for the treatment of skin infections and diseases in fish. Ichthyophthirius multifiliis infection and bacterial and fungal infections are the most common skin diseases observed in farmed fish. With the growing aquaculture industry worldwide to meet the rising demand for seafood, there is a parallel increase in the risk of fish skin infections due to intensification of fish production.
The global fish skin disease Market is estimated to be valued at US$ 1.84 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Rising aquaculture industry is one of the key drivers driving the growth of the fish skin disease market. Aquaculture is the world’s fastest growing food production sector and accounts for about 50% of all fish consumed for human nutrition globally. Increasing adoption of intensive fish farming practices has led to higher density of fish populations which increases the risk of transmission of infectious diseases. Environmental stress factors associated with intensive aquaculture further predispose fish to skin infections and diseases. This is expected to drive the demand for parasiticides, antibiotics and antifungals for treatment of various bacterial, parasitic and fungal infections afflicting farmed fish species.
Additionally, development of novel drug formulations for fish skin diseases is also expected to present lucrative growth opportunities. Pharmaceutical companies are focused on development of innovative treatment options that are more efficacious and cause minimum resistance and side-effects in farmed fish.
Segment Analysis
The global fish skin disease market is segmented based on product type, species type and distribution channel. Based on product type, the market is segmented into topical application and oral medication, among which the topical application segment dominates the market and accounts for around 60% share of the global market. This is because topical applicatons drugs such as anti-fungal and anti-bacterial creams, lotions and ointmentsprovide quicker relief from infections and inflammation.
PEST Analysis
Political: The fish farming industry is increasingly regulated with regulations pertaining to fish welfare, environmental protection and product quality. This impacts R&D investements by key players.
Economic: Rising disposable incomes and growing demand for seafood has boosted fish farming. However, rising costs of fish feed and medicines impacts profitability of fish farmers.
Social: Rising health conciousness among consumers drives demand for quality fish products free from antibiotics and chemicals. This influences treatment options adopted by fish farmers.
Technological: Advancements in disease diagnosis techniques enable early detection while development of novel drugs aids treatment. Smart fish farming leveraging IoT and automation can help monitory fish health.
Key Takeaways
The Global Fish Skin Disease Market Size was valued at US$ 1.84 Bn in 2023 and is projected to reach US$ 2.37 Bn by 2030, expanding at a CAGR of 4.1% during the forecast period.
Regional analysis – Asia Pacific accounts for around 35-40% share of the global market led by countries such as China, India, Vietnam and Bangladesh. This is due to the large fish farming industry in the region.
Key players РKey players operating in the fish skin disease market are Bayer AG, Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co., Inc., Virbac S.A., Ceva Sant̩ Animale, Elanco Animal Health, Bimeda, Aurobindo Pharma Limited, and Teva Pharmaceutical Industries Ltd. Bayer AG and Zoetis Inc capture major market share due to their diverse product portfolios and global presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
